CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), today announced plans to reorganize its business operations and pipeline priorities to support goals for long-term business ...
Sage Therapeutics cut more than half of its workforce in a restructuring move that slams postpartum drug Zulresso and the sales team promoting it. The estimated 340 employees laid off primarily worked ...
Strengthened financial position with expected annualized net savings of approximately $240 million anticipated to extend cash runway into 2026 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results